← FDA DRUG APPROVALS

FDA ANDA · ANDA085732

PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE

Sponsor: WATSON LABS

APPLICATION
ANDA085732
TYPE
ANDA
ORIGINAL APPROVAL
1978-08-21
LATEST ACTION
1989-03-09
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINEDiscontinued
ASPIRIN 389MG, CAFFEINE 32.4MG, PROPOXYPHENE HYDROCHLORIDE 65MG · CAPSULE · ORAL

Approval history

1989-03-09Labeling · Supplement 18AP
1978-08-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →